The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
98616583 9861658 3 F 20110524 20140130 20140203 20151001 EXP US-ROCHE-1271758 ROCHE 40.72 YR F Y 68.10000 KG 20151001 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
98616583 9861658 1 PS LUCENTIS RANIBIZUMAB 1 Other RIGHT EYE, 0.5 MG/0.05 ML 521533,557427,569329,497337,92709 125156 .5 MG
98616583 9861658 2 SS LUCENTIS RANIBIZUMAB 1 Other (0.5 MG/0.05 ML), MOST RECENT DOSE 521533,557427,569329,497337,92709 125156 .5 MG
98616583 9861658 3 SS LUCENTIS RANIBIZUMAB 1 Other 0.05 ML 521533,557427,569329,497337,92709 125156 .3 MG /month
98616583 9861658 4 SS LUCENTIS RANIBIZUMAB 1 Other 0.05 ML 521533,557427,569329,497337,92709 125156 .5 MG /month
98616583 9861658 5 SS AVASTIN BEVACIZUMAB 1 Other 125085
98616583 9861658 6 C ASA ASPIRIN 1 Unknown 0 325 MG
98616583 9861658 7 C COZAAR LOSARTAN POTASSIUM 1 0
98616583 9861658 8 C FISH OIL FISH OIL 1 0
98616583 9861658 9 C METFORMIN HYDROCHLORIDE. METFORMIN HYDROCHLORIDE 1 Unknown 0 500 MG TABLET
98616583 9861658 10 C ZADITOR KETOTIFEN FUMARATE 1 Unknown AS NEEDED OU 0 1 GTT
98616583 9861658 11 C ASPIRIN. ASPIRIN 1 Unknown 0 325 MG
98616583 9861658 12 C METFORMIN HYDROCHLORIDE. METFORMIN HYDROCHLORIDE 1 Unknown 0 500 MG
98616583 9861658 13 C TOBRAMYCIN. TOBRAMYCIN 1 Unknown QID FOR SEVERAL DAYS 0
98616583 9861658 14 C TROPICAMIDE. TROPICAMIDE 1 Unknown 0 1 PCT
98616583 9861658 15 C PHENYLEPHRINE PHENYLEPHRINEPHENYLEPHRINE HYDROCHLORIDE 1 Unknown 0 2.5 PCT
98616583 9861658 16 C BETADINE POVIDONE-IODINE 1 Unknown FLUSH 0
98616583 9861658 17 C CIPROFLOXACIN. CIPROFLOXACIN 1 0
98616583 9861658 18 C POVIDONE POVIDONE 1 Unknown 0 5 PCT
98616583 9861658 19 C OFLOXACIN. OFLOXACIN 1 0
98616583 9861658 20 C POLYTRIM POLYMYXIN B SULFATETRIMETHOPRIM SULFATE 1 Unknown 0 QID
98616583 9861658 21 C PROPARACAINE PROPARACAINE 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
98616583 9861658 1 Cystoid macular oedema
98616583 9861658 2 Neovascular age-related macular degeneration
98616583 9861658 3 Retinal telangiectasia
98616583 9861658 4 Neovascular age-related macular degeneration
98616583 9861658 5 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
98616583 9861658 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
98616583 9861658 Blood glucose increased
98616583 9861658 Chorioretinal scar
98616583 9861658 Conjunctival hyperaemia
98616583 9861658 Conjunctivitis allergic
98616583 9861658 Cystoid macular oedema
98616583 9861658 Eye inflammation
98616583 9861658 Glaucoma
98616583 9861658 Macular degeneration
98616583 9861658 Metamorphopsia
98616583 9861658 Photopsia
98616583 9861658 Retinal disorder
98616583 9861658 Vision blurred
98616583 9861658 Visual acuity reduced
98616583 9861658 Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
98616583 9861658 1 20100405 0
98616583 9861658 2 20140109 0